Tazarotene 73473-0310
Product NDC
73473-0310- Manufacturer
- Solaris Pharma Corporation
- Dosage Form
- Gel
- Route
- Cutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 3, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA213644
Need to source Tazarotene? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tazarotene | 1 mg/g |
Drug Class
Retinoid [EPC]Retinoid [EPC]Retinoids [CS]
Packaging Options(2)
1 TUBE in 1 CARTON (73473-310-10) / 100 g in 1 TUBE
1 TUBE in 1 CARTON (73473-310-30) / 30 g in 1 TUBE